Further studies are needed to elucidate how AST represses the expression of CSC genes at the transcriptional or translational levels, what quantities of AST provide optimal cancer treatment effects, and the relationship between pontin and hsp90 during AST treatment for breast cancer. This evidence concerns the gene RUVBL1 and breast cancer.